As the second-oldest atypical antipsychotic, risperidone has a long history of off-label usage for treating behavioural and psychological signs and symptoms of dementia (BPSD), such …
Naloxone is an opioid receptor antagonist that can eradicate all pre-indications of the toxicity and inverse the opioid overdose. However, oral administration of naloxone offers limitations …
V Pasupuleti, L Vora, R Prasad… - … et Biophysica Acta (BBA …, 2024 - Elsevier
Glioblastoma multiforme is a highly malignant brain tumor with significant intra-and intertumoral heterogeneity known for its aggressive nature and poor prognosis. The complex …
A Majchrzak-Celińska, R Kleszcz, E Studzińska-Sroka… - Cells, 2022 - mdpi.com
Lichens are a source of secondary metabolites with significant pharmacological potential. Data regarding their possible application in glioblastoma (GBM) treatment are, however …
HD Nguyen - Toxicology and Applied Pharmacology, 2023 - Elsevier
Although there is an association between heavy metals and glioma, the molecular mechanisms involved in glioma development remain unclear. Therefore, this study aimed to …
VJ Iyer, JE Donahue, MA Osman - Cell Communication and Signaling, 2024 - Springer
Glioblastoma (GB) is a highly heterogeneous type of incurable brain cancer with a low survival rate. Intensive ongoing research has identified several potential targets; however …
Cardiomyocyte regeneration following cardiac damage is challenging to study because of the inflammatory process, the multiplication of cells in the stroma, and the creation of scar …
AC Fuentes-Fayos, JM Pérez-Gómez - Int. J. Mol. Sci, 2022 - academia.edu
Glioblastoma (GBM) is the most malignant and lethal brain tumor. Current standard treatment consists of surgery followed by radiotherapy/chemotherapy; however, this is only a …
N Dogra, P Singh, A Kumar - Molecular Neurobiology, 2024 - Springer
Glioblastoma (GBM) is the highest grade of glioma for which no effective therapy is currently available. Despite extensive research in diagnosis and therapy, there has been no …